CHICAGO (AP) — Hopes are rising again for a drug to alter the course of Alzheimer's disease after repeated failures. Two drug companies said that an experimental therapy they are developing slowed mental decline by 30 percent in patients who got the highest dose.Read more on NewsOK.com